Page last updated: 2024-11-06

benzimidazole and Budd-Chiari Syndrome

benzimidazole has been researched along with Budd-Chiari Syndrome in 1 studies

1H-benzimidazole : The 1H-tautomer of benzimidazole.

Budd-Chiari Syndrome: A condition in which the hepatic venous outflow is obstructed anywhere from the small HEPATIC VEINS to the junction of the INFERIOR VENA CAVA and the RIGHT ATRIUM. Usually the blockage is extrahepatic and caused by blood clots (THROMBUS) or fibrous webs. Parenchymal FIBROSIS is uncommon.

Research Excerpts

ExcerptRelevanceReference
"Benzimidazole (BZM) treatment is given in inoperable cases but these compounds are only parasitostatic, and lifelong therapy is required."1.32Indications and results of liver transplantation for Echinococcus alveolar infection: an overview. ( Bresson-Hadni, S; Gillet, M; Heyd, B; Koch, S; Mantion, GA; Miguet, JP; Vuitton, DA, 2003)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bresson-Hadni, S1
Koch, S1
Miguet, JP1
Gillet, M1
Mantion, GA1
Heyd, B1
Vuitton, DA1

Other Studies

1 other study available for benzimidazole and Budd-Chiari Syndrome

ArticleYear
Indications and results of liver transplantation for Echinococcus alveolar infection: an overview.
    Langenbeck's archives of surgery, 2003, Volume: 388, Issue:4

    Topics: Adolescent; Adult; Aged; Anthelmintics; Benzimidazoles; Budd-Chiari Syndrome; Comorbidity; Decision

2003